Fortive Q3 2026 Earnings Call Transcript

Fortive (NYSE:FTV) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.

This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation.

View the webcast at https://event.choruscall.com/mediaframe/webcast.html?webcastid=d5ChtBvy

Summary

Fortive Corporation reported strong financial performance in Q3 2026, with core revenue growth of 7.2%, adjusted EBITDA growth of approximately 10%, and adjusted EPS growth of 13%.

The company executed $300 million in share repurchases, bringing the total to $2.3 billion since the launch of ‘New Fortive’, representing 13% of shares outstanding.

Fortive raised its full-year 2026 adjusted EPS guidance to $3.10 to $3.14, reflecting a 15% year-over-year increase at the midpoint.

Strategic initiatives in innovation and commercial capabilities are driving growth, with new product introductions at Fluke and a reimagined platform at Industrial Scientific.

Management expressed confidence in the Fortive Accelerated strategy, which is contributing to improved business performance and future sustainable growth.

Q3 adjusted EBITDA was $340 million, with a margin expansion of 50 basis points year-over-year to 30.6%, driven by adjusted gross profit growth and cost savings.

The Advanced Healthcare Solutions segment saw revenue growth of 3.7% year-over-year, with plans for long-term growth through investments in innovation and commercial capacity.

The company is maintaining a disciplined capital allocation approach, focusing on organic growth, bolt-on M&A, and shareholder returns.

Fortive is optimistic about continued growth in its Intelligent Operating Solutions segment, driven by demand in professional instrumentation and facility lifecycle solutions.

Management highlighted the potential for continued success in the data center market, with increased sales force and product innovation tailored to hyperscaler needs.

Full Transcript

Darrell (Conference Facilitator)

My name is Darrell and I will be your conference facilitator this afternoon. At this time I would like to welcome everyone to Fortive Corporation’s third quarter 2026 earnings results conference call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question and answer session. If you would like to ask a question during that time, simply press star then the number one on your telephone keypad.

If you would like to withdraw your question, press star then the number two on your telephone keypad. I would now like to turn the call over to Ms. Christina Jones, Vice President of Investor Relations. Ms. Jones, you may begin your conference.

Christina Jones (Vice President of Investor Relations)

Thank you. And thank you everyone for joining us on today’s call. I am joined today by Olumide Soroye, Fortive’s President and CEO, and Mark Okerstrom, Fortive’s CFO. During today’s call we present certain non-GAAP financial measures. Information required by Regulation G is available on the Investors section of our website at fortive.com. We will also make forward-looking statements, including statements regarding events or developments that we expect or anticipate will or may occur in the future.

These forward-looking statements are subject to a number of risks and actual results might differ materially from any forward-looking statements that we make today. Information regarding these risk factors is available in our SEC filings, including our annual report on Form 10-K and the subsequent quarterly reports on Form 10-Q. These forward-looking statements speak only as of the date that they are made and we do not assume any obligation to update any forward-looking statements.

Our statements on period-to-period increases or decreases refer to year-over-year comparisons unless otherwise specified and our results and outlook discussed today are on a continuing operations basis. With that, I’ll turn the call over to Olumide.

Olumide Soroye (President and CEO)

Thank you, Christina, and thank you all for joining our call today. Let me begin on slide 3. Q3 marked our fifth consecutive quarter of strong execution and sequential core growth acceleration as we advance our Fortive Accelerated strategy. Four key messages from the quarter: first, our teams delivered strong financial results including core revenue growth of 7.2%, adjusted EBITDA growth of approximately 10% and adjusted EPS growth of 13%. These results reflect continued organic growth acceleration driven by healthy customer demand and strong execution enabled by our Fortive Business System.

Second, we maintained our disciplined approach to capital allocation. This quarter we deployed another $300 million towards share repurchases, bringing total capital return through share repurchases since the launch of New Fortive to $2.3 billion, representing 13% of shares outstanding. Third, our Fortive Accelerated strategy is translating into improving business performance across the portfolio. Our investments in innovation, commercial and recurring customer value are driving faster, profitable growth and reinforcing our confidence in the company’s long-term value creation opportunity.

Finally, we are raising our full year 2026 adjusted EPS guidance to $3.10 to $3.14, up 15% year over year at the midpoint, reflecting our strong year-to-date performance and continued confidence in the trajectory of the business. Moving to slide 4, let me highlight some of the progress we are making in executing the three pillars of our Fortive Accelerated strategy, starting with our first pillar, delivering faster, profitable organic growth. We are pleased with the progress we’re seeing across innovation, commercial and recurring customer value, all of which are building the foundation for durable, faster organic growth. This quarter our innovation engine continued to generate new growth opportunities.

At Fluke, we expanded our innovation funnel with several new product introductions, including thermal and acoustic imagers, which broaden our reach to early-in-career technicians with intuitive entry-level diagnostic capabilities. At Industrial Scientific, we launched iNet Insights, a completely reimagined platform that helps customers manage sophisticated gas detection programs and large detector fleets while expanding the capabilities and value of our recurring iNet subscription offering.

In Facilities and Asset Lifecycle Solutions, we continue to embed AI more deeply into customer workflows. For example, at ServiceChannel, our R2 release introduced new capabilities including AI-powered asset recognition and intelligent agents that not only help create and route work orders but also identify stalled work orders, recommend next best actions and help drive issues to resolution. On the commercial side, we maintained our focus on faster-growing end markets and regions where we’ve made deliberate, targeted investments to capture growth. At Fluke, we continue to build commercial capabilities aligned to our strategic growth priorities including data centers, defense and early-in-career technicians. During the quarter, we expanded our specialized data center sales capabilities and capacity, secured initial orders for our new early-in-career product bundle and strengthened relationships with educational organizations to engage the next generation of skilled technicians.

At Industrial Scientific, we continue to build commercial momentum for our recently acquired Aeroqual environmental monitoring business in North America and commenced manufacturing these products in our U.S. facilities, improving customer lead times and leveraging our combined footprint and Fortive Business System capabilities to drive greater operational efficiency. In Healthcare, ASP and Provation continue to deepen engagement with ambulatory surgical centers through focused commercial resources, targeted partnerships and innovative customer adoption pathways that expand our installed base and improve customer access to our solutions.

On our recurring customer value initiatives, we made further progress on deepening customer lifecycle engagement and improving revenue durability. In Q3, we again saw solid recurring revenue growth across both segments. As an example, at Fluke, recurring revenue growth was supported by continued momentum in our eMaint software platform, including increasing customer adoption of recently launched AI-enabled capabilities. During the quarter, eMaint secured several significant customer wins and continued to advance customer migrations to our next-generation platform.

We are pleased that our Fortive Accelerated growth initiatives are not only building a strong foundation for future sustainable, profitable growth, but also increasingly translating into our current results, contributing to sequential core growth acceleration in each of the last five quarters since the launch of New Fortive. Moving to our second pillar, disciplined capital allocation is an integral component of our Fortive Accelerated strategy. Consistent with our priorities, we deployed another $300 million towards share repurchases in the third quarter. We continue to evaluate high-quality bolt-on opportunities and recent acquisitions are performing well and contributing to growth.

Looking forward, our capital allocation priorities remain clear: invest in organic growth, pursue bolt-on M&A where risk-adjusted returns exceed other uses of capital, return capital through share repurchases and maintain a modest, growing dividend, all with a focus on maximizing medium- to long-term shareholder value. Moving to our final pillar, building and maintaining investor trust, we are pleased to deliver another quarter of strong performance ahead of expectations as we continue to build our track record of consistent execution, and we remain fully confident in our medium-term financial framework from Investor Day. With that, I’ll turn it over to Mark to walk through our financial results for the third quarter in more detail.

Mark Okerstrom (Chief Financial Officer)

Thanks, Olumide. I’ll begin with slide five. In the third quarter we delivered total revenue of $1.1 billion, up 8% year over year on a reported basis and up 7% on a core basis. We saw price and volume growth in both segments with particularly robust performance. In our IOS segment, growth was driven by accelerating demand for professional instrumentation, continued momentum in facility and asset lifecycle solutions’ mission-critical enterprise software solutions, and ongoing strength in gas detection, reflecting the benefits of our growth investments and disciplined operational execution enabled by the Fortive Business System.

Regarding core growth by geography, all major regions contributed to growth this quarter. North America remained our strongest performing region and saw modest sequential acceleration in Q3. Revenue growth in Europe, Middle East and Africa accelerated with particular strength in professional instrumentation. APAC and LATAM also performed well. Adjusted gross margin was about 63% in the quarter, down 80 basis points year over year. Adjusted gross margin performance was primarily driven by product mix dynamics resulting from outsized growth in certain lower margin products, partially offset by operating leverage. Price-cost remained solidly positive in the quarter. While inflationary pressures have increased, the team continues to leverage the Fortive Business System, including sourcing and productivity countermeasures, to offset inflation across both segments.

Our industry-leading gross margins reflect both the differentiation of our products and the effectiveness of our Fortive Business System in sustaining those margins over time. The growth investments or mix shifts in any given quarter may cause fluctuations. These movements fit within a broader arc of strong gross margin discipline. Q3 adjusted EBITDA was $340 million, up 10% year over year. This favorable performance was driven by adjusted gross profit growth, operating leverage and discrete structural cost savings, partially offset by growth investments to support our Fortive Accelerated strategy. Adjusted EBITDA margin in the quarter expanded by 50 basis points year over year to 30.6%. Note that our consolidated adjusted EBITDA margins faced a roughly 50 basis point year over year headwind stemming from the annualization of certain discrete cost benefits we saw in Q3 of last year.

We continue to be pleased with our ability to drive solid margin expansion and invest further into Fortive Accelerated strategic growth initiatives, and we remain fully confident in our ability to deliver 50 to 100 basis points of annual adjusted EBITDA margin expansion as outlined in our Medium Term Financial Framework. We delivered adjusted earnings per share of $0.77 in Q3, up over 13% year over year, marking our fifth consecutive quarter of double digit adjusted EPS growth. Strong adjusted EPS performance in Q3 was driven by growth in adjusted EBITDA and the positive year over year impact of share repurchases, partially offset by higher interest and tax expense. We generated over $280 million of free cash flow in the third quarter, with our trailing twelve month free cash flow above $1 billion and conversion on net income well north of 100%.

Please note that during the quarter we recognized an $18 million IEEPA tariff refund benefit in GAAP earnings and free cash flow. We expect another $5 to $10 million of tariff refunds in the coming quarters. As we did last quarter, we exclude the benefit of IEEPA tariff refunds from our adjusted earnings metrics and expect to continue doing so going forward. We do, however, include the benefit in free cash flow, as the cash proceeds are real and available for deployment under our disciplined capital allocation framework.

Moving to our segment results, starting with Intelligent Operating Solutions on Slide 6, revenue for the segment grew 10% on a reported basis with core revenue growth accelerating to 9%, and we are pleased to see broad momentum continue across the segment. Core growth acceleration was driven by robust volume growth in professional instrumentation, facility and asset lifecycle solutions, and gas detection products. At Fluke, we delivered strong, broad-based growth led by our industrial and network product portfolios.

Orders growth again accelerated from an already strong pace in the second quarter, and book-to-bill remained above one, reflecting the success of Fluke’s strategic repositioning towards higher growth applications. As part of our Fortive Accelerated strategy, we delivered growth in all regions, again led by North America and complemented by acceleration in Europe. We also continued to invest behind strategic growth priorities including data centers, defense, and early-in-career technicians, where we see attractive opportunities to extend our market leadership and enhance the durable growth profile of our largest operating brand.

Growth in facility and asset lifecycle solutions also accelerated in the third quarter, led by sustained outperformance in multi-site facility maintenance and marketplace software at ServiceChannel, as well as planning and procurement solutions at Gordian. We believe this performance reflects the early benefits of our commercial and innovation investments, which are driving deeper customer engagement and increased demand for our AI-enhanced solutions.

Growth in our gas detection business also increased sequentially, driven by growing demand for our worker safety solutions, including our hardware-as-a-service offerings in North America, Europe and the Middle East, all bolstered by Fortive Accelerated investments in expanded commercial capabilities across the globe. Adjusted gross margin in the segment was just under 65%, reported roughly flat sequentially and down 90 basis points year over year, primarily due to strong growth from some of our lower margin products serving select multi-site retail customers with high strategic value, partially offset by operating leverage.

Q3 adjusted EBITDA in the segment grew 13% to $275 million driven by adjusted gross profit growth, operating leverage and discrete structural cost savings, partially offset by growth investments including sales and marketing and R&D investments. At Fluke and Industrial Scientific, adjusted EBITDA margin for Q3 expanded by 120 basis points year over year to just under 36%, reflecting the strength of our operating performance and continued cost discipline.

Moving to our Advanced Healthcare Solutions segment on Slide 7, we delivered total revenue of $340 million. Revenue grew 3.7% year over year and 3.1% on a core basis. Q3 growth was broad-based and benefited from momentum in several areas. Low temperature sterilization capital contributed to growth in the quarter, and we saw solid demand for healthcare consumables, including in Latin America and APAC. Biomedical testing equipment and radiation monitoring solutions showed strong growth in the quarter, and Provation SaaS products continue to deliver accretive growth driven by solid provider demand for our gastrointestinal case documentation solution and strategic initiatives to expand to adjacent specialties and regions. Adjusted gross margin in the segment was 57.5%, down 90 basis points year over year, driven primarily by product mix, including strength in emerging market consumable sales, partially offset by operating leverage.

Q3 adjusted EBITDA in the segment was modestly ahead of our expectations at $88 million, down 5% year over year, driven by growth investments and the lapping of certain discrete cost benefits realized in Q3 of last year, partially offset by operating leverage. Adjusted EBITDA margin contracted by 230 basis points year over year on these same factors, but remained essentially flat sequentially at 26%. The year over year headwind from the annualization of prior year discrete cost benefits was roughly 100 basis points.

We continue to invest in attractive AHS growth opportunities and remain fully confident that over the medium term these investments will drive core growth and margin expansion in the segment. Turning to Slide 8, as noted earlier, we deployed $300 million to share repurchases in the third quarter, reflecting our disciplined capital allocation approach. As a result, we had 302 million diluted shares outstanding at the end of Q3. Since the launch of New Fortive, we’ve deployed $2.3 billion to share repurchases, meaningfully enhancing our adjusted EPS growth and return on equity. In terms of M&A, we continue to evaluate high quality, accretive bolt-on deals that meet our rigorous strategic and financial criteria and deliver superior returns relative to alternative uses of capital.

As New Fortive, we have completed several bolt-on acquisitions including Aeroqual and UV Smart, and these acquisitions are performing solidly in line with our deal cases, and we expect them to contribute to accelerating growth over the years to come. We were also pleased to raise our quarterly dividend by 17% in Q3, consistent with our desire to maintain a modest and growing dividend. From a balance sheet perspective, we finished the quarter at 2.6 times gross debt to adjusted EBITDA, modestly deleveraging from last quarter and solidly within our financial policy of keeping ordinary course leverage within a range around 2.5 times gross debt to adjusted EBITDA.

Moving to slide 9, we are raising our full year 2026 adjusted EPS guidance range to $3.10 to $3.14 per share, representing just over 15% year over year growth at the midpoint, reflecting strong year to date performance and confidence in the trajectory of the business. This outlook assumes a continuation of the market dynamics we experienced in Q3 and reflects current tariff rates. Let me provide a few additional considerations to assist with modeling.

In terms of the full year, based on current foreign exchange rates, we now expect full year reported revenue just north of $4.4 billion and full year core growth just north of 5%. We expect full year adjusted EBITDA margin expansion around the midpoint of the 50 to 100 basis points range outlined in our medium term financial framework, and we expect full year net interest expense of approximately $145 million. Regarding Q4, as we mentioned last quarter, Q4 will have four fewer selling days versus the prior year’s quarter. This will drive about a $15 to $20 million headwind to reported revenue and a 150 basis point headwind to core growth in the fourth quarter. At the segment level, this translates into a 100 basis point headwind to core growth in IOS and a 300 basis point headwind in AHS. We expect IOS core growth to continue to outperform AHS on a normalized basis.

We expect FX and M&A combined to be about a 50 basis point tailwind to reported revenue in Q4, and we continue to expect a Q4 effective tax rate in the low double digit range. As a final note before turning it back to Olumide for closing remarks and Q&A, our year to date results show that our Fortive Accelerated strategy is working. We remain fully confident in our medium term financial framework from Investor Day, and our sights remain keenly focused on delivering benchmark-beating returns for our shareholders over the medium to long term. I’ll now turn it back over to Olumide.

Olumide Soroye (President and CEO)

Thanks, Mark. Let me close with a few observations on the quarter and where we’re headed. Q3 was another strong quarter for Fortive. We delivered over 7% core growth, approximately 10% adjusted EBITDA growth, and our fifth consecutive quarter of double-digit adjusted EPS growth. We are seeing our Fortive Accelerated strategy translate into stronger operating and financial performance, and our teams remain intensely focused on executing strategic initiatives to further accelerate profitable growth. We are maintaining a disciplined approach to capital allocation, returning meaningful capital to shareholders while pursuing attractive bolt-on acquisitions that meet our rigorous strategic and financial criteria. We remain highly confident that our Fortive Accelerated strategy will unlock significant value for our shareholders.

With that, I’ll turn it back to Christina to open the call for questions.

Christina Jones (Vice President of Investor Relations)

Thanks, Olumide. That concludes our prepared remarks. We are now ready for questions.

OPERATOR

Thank you. We will now be conducting a question-and-answer session. If you would like to ask a question, please press star one on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press star two to remove your question from the queue. For participants using speakerphone equipment, it may be necessary to pick up your handset before pressing the star keys. One moment, please, while we poll for your questions.

Our first questions come from the line of Julia Mitchell with J.P. Morgan. Please proceed with your questions.

Julia Mitchell (Analyst at J.P. Morgan)

Hi, good afternoon. Maybe just a first question, please, around the AHS margin outlook. So I understood there’s that 100 bps or so, I think, headwind—sort of one-off in the quarter—but absent that, sort of margins are still down, maybe a little bit of mix impact. And if we take a step back, you know, margins in AHS have been sort of flattish for a couple of years now. Just wondered if that’s, you know, investment to drive up the organic sales growth rate from the sort of low single-digit trajectory it’s been at, or that’s what’s needed just to stay with that organic growth rate where it is because of competitive reasons and innovation requirements and so forth.

Olumide Soroye (President and CEO)

Hey, Julia, thanks for the question. So maybe just to step back a little bit, we’re just really excited about the profitable growth runway ahead for us at AHS. If you look at year to date versus last year, the top-line core growth is at 4.5%, and we expect acceleration on a full-year basis as well. I think there may be quarterly variations based on timing of orders and selling days, but it all fits in that arc of top-line acceleration. And the work we’re doing this year is to set up chess for a great run of multi-year acceleration in growth and margin expansion. And in doing that, we’re making some deliberate investment this year in growing our install base to kind of power that flywheel of the razor–razor blade model we have at ASP, as an example. We’re building commercial capacity to gain share in ASC/ambulatory surgical centers, and we invest in innovation that’s going to extend our differentiation and power growth for years to come.

Those are deliberate and time-bounded investments that we’re making this year. On a long-term basis, we’re really pleased with what we’re able to do on a top-line growth and margin expansion point of view, but view this year very much as a year of setting the stage for the success of this segment, and we believe it’s going to play a really key role in our multi-year value creation story. So there are short-term things that are happening, but it doesn’t change the long arc of opportunity we have in the segment.

Julia Mitchell (Analyst at J.P. Morgan)

That’s great, thank you. And then just my second one would be around the IOS segment—industrial and manufacturing end market within that, I think, was up low double digits for the second quarter running there in terms of year-on-year growth. So very good performance. Maybe sort of help flesh out any specific drivers around that. And what do you think about the sustainability of this very good growth in that industrial and manufacturing part of IOS?

Olumide Soroye (President and CEO)

Yeah, no, I mean the thing that we really like about IOS and the industrial and manufacturing part is the broad-based nature of the success that our teams are having. Literally across geographies, across brands, across product categories, across price and volume—it’s just great success. And in that particular end market, Julia, that you pointed out, it’s a whole range of drivers of that success, not a single item. And we like that because, to your point about durability and sustainability, that really speaks to the fact that we have a lot of ways to win with so many engines firing at the same time for us in that segment and that end market. So that’s the way I’d describe it: it’s very broad-based, Julia.

Julia Mitchell (Analyst at J.P. Morgan)

Great, thank you.

OPERATOR

Thank you. Our next questions come from the line of Scott Davis with Melius Research. Please proceed with your questions.

Scott Davis (Analyst at Melius Research)

Hey, good—I guess it’s still good morning out there, fellas. And Christina, appreciate the color here on the call. I’m going to ask kind of a stupid question probably, but is there anything different you need to do to serve the data center market? I mean, I understand having a dedicated salesforce perhaps, but is there anything different you need to do from a product perspective or product availability perspective or service or anything else otherwise?

Olumide Soroye (President and CEO)

Yeah, thanks for the question. I mean, we’re just—and I’m going to take that question in the context of Fluke, which is our biggest operating brand and doing incredibly well with our team executing at a high level. And we’re really excited about the data center opportunity. As you know, we participate in the construction and build-out phase as well as in the enduring ongoing operations and maintenance of these data centers. We already are well positioned with a broad portfolio of market-leading solutions that ranges from power quality monitoring analytics to power calibration, high-voltage diagnostics, electric ground fault detection.

So we have a lot of things already, Scott, that really go into that segment, both in the initial construction, certification, and aftermarket. The exciting work that our team’s doing now is really ramping up the pace of innovation to come up with new products that solve problems that are new for these hyperscaler data centers that didn’t exist with conventional data centers. And we’ve talked about the CertiFiber Max as an example of a product that’s really designed for these really high-gigabyte data centers in a way that no one else is doing. And that’s pulling through everything else that we do in the data center.

So the work that we’re doing is really adding more innovation like that, and then building, as we talked about in our prepared remarks, our commercial capacity, because literally we just need a bigger sales team, a bigger specialized data center team to go take these exciting offerings to the range of customers we now have. So we’re on the chase, as you can imagine, intensely. We’re excited about the upside ahead of us, and we’re still early.

Scott Davis (Analyst at Melius Research)

It makes sense. And then, switching gears, I don’t know if you answered this question specifically in prepared remarks, because I didn’t hear it. What are your customers telling you on the healthcare side as far as their capital spending budgets near, medium, longer term? I mean, it feels like the hospital segment has been in kind of a recession forever. Is there any light at the end of the tunnel on kind of a replacement cycle out there that you guys could see perhaps in ’27 or so?

Olumide Soroye (President and CEO)

Yeah, thanks for that. You know, I’ve had a chance personally to spend time with our teams, with customers around the world in the healthcare segment. And, you know, the way I’ll describe it overall—maybe just start with the U.S. market—is that the environment is improving with hospitals. They’ll continue to navigate through a dynamic kind of operating and policy environment, but procedure volumes overall remain healthy. Capital spending trends are more supportive than they were last year, and they continue to improve.

They’re still somewhat constrained. We continue to see shift in elective procedures towards ambulatory surgery centers, which again creates an opportunity for us because our teams are now getting really good at being a leader in serving these ASCs. So overall, you know, I would say the environment is stable to improving in the U.S. Outside of the U.S., it’s really a strong market we’re seeing. There’s a lot more spending going into healthcare in different pockets around the world for different reasons. So overall, stable and improving. In the U.S. it’s always dynamic, but we like the trend that we’re seeing, and really good outside the U.S. So overall, we’ll take our chances on our own ability to execute and outperform the market on a market that’s stable and improving.

Scott Davis (Analyst at Melius Research)

Okay, I’ll pass it on. Thanks and best of luck. Olumide, appreciate it. And Mark and Christina, see you guys.

Christina Jones (Vice President of Investor Relations)

Thanks, Scott.

OPERATOR

Thank you. Our next questions come from the line of Alexander Virgo with Evercore ISI. Please proceed with your questions.

Alexander Virgo (Analyst at Evercore ISI)

Oh, yeah, thanks very much, gentlemen. Christina, appreciate you taking us. I wonder if you could just talk a little bit more about two things—and I guess I’m thinking more about IOS than AHS here—but I wonder if you could begin: innovation momentum, any kind of sense of contribution you can give us in terms of how much it’s given you in terms of the organic growth. And then on the recurring revenue side, I just wondered whether you can give us any more color, any more sense or quantitative indications on growth there.

That’d be really helpful. Thank you.

Olumide Soroye (President and CEO)

Yeah, no, thanks—thanks for the question. I’ll just maybe go in reverse with respect to recurring revenue growth. This is an exciting story for us. We saw really strong growth in both recurring and non-recurring revenue this quarter. And it’s an interesting time because the non-recurring revenue actually grew faster, and that’s driven by just really strong performance at our Fluke business. The interesting thing is we’ve always viewed recurring revenue as an indicator of durability, but it’s not the only indicator of durability. And many of our hardware businesses that are, in quotes, non-recurring, have demonstrated exceptional durability through the strength of the brand, the differentiated technology, kind of the recurring replacement cycles. Fluke, as an example, is seeing order growth non-stop every quarter now for several years, and that’s as good as a recurring business.

So overall, strong growth on both sides, but just interesting that the non-recurring actually grew faster in this quarter. From the point of view of innovation, we’ve talked about our Fortive Accelerated strategy as being anchored in this deep belief that we can grow this portfolio faster, organically and profitably. Obviously, innovation is a key element of that—so is commercial—and recurring customer value for the customers we already have. The contribution to innovation, you’re seeing that show up across the brands. The fact that we have Fluke in the IOS segment and every piece of the IOS segment growing at the pace that we saw here in the quarter, and the AHS segment accelerating from where they were last year to year-to-date 4.5% core growth.

All of our brands are driving innovation, and that’s showing up in those numbers. The way innovation shows up: it’s sometimes in pricing power, sometimes in volume, and it’s sometimes in just customer retention and loyalty. We’re tracking those in detail, as we always do with our Fortive Business System, and we like the contribution from innovation.

Alexander Virgo (Analyst at Evercore ISI)

Very helpful. Thank you very much.

OPERATOR

Thank you. Our next questions come from the line of Quinn Frederickson with Baird. Please proceed with your questions.

Quinn Frederickson (Analyst at Baird)

Hey, good morning. Just wanted to ask about the fourth quarter outlook. I think if I got the moving pieces right, you might be implying kind of flattish core sales. I know you have the days impact and the comp is a little tougher. Is that just the main factors, or are there any other factors to be aware of that drive a little bit of the deceleration in 4Q core growth?

Mark Okerstrom (Chief Financial Officer)

Sure, Quinn, happy to take that. You know, just as a reminder of what we said, we’re expecting core growth on a full-year basis of just north of 5%, as you called out. There is the days factor, which is the primary sort of normalization in the quarter. It’s 150 basis points on a consolidated basis, $15 to $20 million on a reported basis, and we would expect that to hit roughly 100 basis points to IOS and about 300 basis points to AHS. But that’s the primary driver. Again, we really like the course and speed of the business right now. We’re carrying good momentum here coming out of the third quarter, and the arc of the business is really one of acceleration.

Quinn Frederickson (Analyst at Baird)

All right, thank you for those details. Secondarily, just on pricing in AHS, it looked like it took a step higher sequentially—280 basis points versus 190 last quarter. Should we think about that as a sustainable level of price contribution for the next few quarters?

Mark Okerstrom (Chief Financial Officer)

I think about that range. I think a couple hundred basis points, give or take, is a good marker. I think what you’ve seen in both IOS and AHS really goes to what Olumide was talking about, which is the teams have increased the pace of innovation that’s enabled them to maintain strong pricing power. You saw that in AHS, you see that in IOS, and I would expect that to continue through the balance of the year and out through 2027.

Quinn Frederickson (Analyst at Baird)

Great. Thanks, Mark.

Mark Okerstrom (Chief Financial Officer)

You’re welcome.

OPERATOR

Thank you. Our next questions come from the line of Brandon Knutson with Morgan Stanley. Please proceed with your questions.

Brandon Knutson (Analyst at Morgan Stanley)

Good morning. Thanks for taking my question. You highlighted on the data center front increasing sales force there that’s focused on that market. Can you provide some tangible examples of how your investments in sales force, new product development, et cetera, are showing up in the business? Like, are you working with more hyperscalers? Are you outgrowing the market, accelerating versus Q2? Any way to quantify the ROI you’re seeing there? And then roughly what percent of your revenue is levered to data centers?

Olumide Soroye (President and CEO)

Yeah, let me start with the last part of your question. You know, data center, like I mentioned, is just an incredibly exciting opportunity for us as a company, and we’re still very early. And the way you see that is today, if you estimate how much of overall Fortive revenues is from the data center ecosystem, it’s still low single digits that we’re talking about. So we’re still really early. And so the investments we’re making, knowing that it could be a lot bigger of an opportunity for us, include things like innovation. We now have a roadmap of innovation that’s aimed toward solving problems for data centers and capturing opportunities in terms of actually realizing the value from the huge capital investments going into the data centers. And we are, to your point, in deep discovery with a lot of the hyperscalers on what is needed.

One of the things I enjoy is spending time with our teams at some of these hyperscalers, so we’re really coming up with things that only Fluke, with a deep expertise in professional instrumentation and precision measurement, can solve for them. And we’re going to be coming with more and more of those new products. From a commercial point of view, you need, frankly, just feet on the street to cover the range of a number of hyperscalers. But not just hyperscalers—it’s also the building and construction firms that work with them. It’s the technical advisors that work with them on designing and spec’ing out these data centers. It’s not just in the U.S.; we’re doing that globally. So we’re adding the capacity and the expertise we need to cover the market well and effectively.

Those are the kinds of things that we’re doing. From an ROI point of view, we’re really happy with what we’re seeing. And, you know, frankly, we’re supply constrained at this point in terms of the talent and the capacity we want to build, because the market is certainly there for us.

Brandon Knutson (Analyst at Morgan Stanley)

Great, thank you. And then on IOS, you highlighted last quarter, I think, that you’ve had the multisite retailer mix increasing, driving headwinds on operating margins or gross margins—same thing this quarter. Is that a dynamic that’s getting bigger sequentially in terms of more activity there, or is it kind of consistent that we should expect going forward?

Mark Okerstrom (Chief Financial Officer)

I would expect it broadly consistent. You know, it’s probably consistent this quarter in terms of impact with what we saw last quarter. As a reminder, this is a product offering that ServiceChannel has where they are essentially the outsourced providers for facility maintenance. And one of the types of arrangements we enter into with strategic partners is an arrangement where we end up being the merchant of record on the spend. And so, optically, from a reported basis it does sort of gross up the P&L to some extent.

But it’s still a great business, and we’re going to continue to push it. But I would think about it as something that is not going to be an increasing factor for us going forward.

Brandon Knutson (Analyst at Morgan Stanley)

Great. Thank you.

Mark Okerstrom (Chief Financial Officer)

You’re welcome.

OPERATOR

Thank you. Our next questions come from the line of Nigel Koh with Wolfe Research. Please proceed with your questions.

Nigel Koh (Analyst at Wolfe Research)

Oh, thanks. Good morning, everyone. Good morning. Just want to stick on that topic, actually. So I think we’ve covered the product cost mix issues in both segments. Maybe, Mark, could you just talk about the inflation impacts, because when you’ve got 60% gross margin, it’s really tough to maintain the margin with the inflation. So just wondering if that’s also a measurable impact. And then, within that, maybe just touch on where we are right now with the memory inflation and how that looks into next year.

Mark Okerstrom (Chief Financial Officer)

Yeah, happy to take that, Nigel. I think, first of all, I would say that Fortive, by virtue of the incredible brands that we’ve got, the differentiated product offerings that we have, and the power of the Fortive Business System, has a long track record of real gross margin discipline, and we expect that to continue going forward. This quarter we did see an increased impact from inflation, but price/cost was strongly positive, and the teams just do an excellent job—this quarter being no exception—in offsetting inflation with value engineering, procurement activities, supply chain activities.

And again, this was no exception. And when you layer price on top, again, strongly positive. We did see particular inflation this quarter on electrical and electronic componentry. Freight was up more than we expected. The teams were, again, more than able to more than offset—as a testament to what they’ve been able to achieve with the Fortive Business System. And really in both segments, as you call out, the drivers of gross margin contraction—even though it’s quite modest—were driven by mix shift and the ServiceChannel offering we mentioned, and then in the healthcare segment driven by stronger growth in lower-margin consumables, particularly in Asia and Latin America.

So I think you’re going to expect to see us continue to be able to drive strong gross margins going forward. From quarter to quarter you may see mix impacts, or we may make discrete investments, but strong gross margins are really part of the Fortive playbook.

Nigel Koh (Analyst at Wolfe Research)

Great, thanks, Mark. That’s good color. And then, Olumide, maybe just double click on what’s going on in the FAL portfolio and maybe the AHS software as well. Obviously a lot of fluidity right now in software models. You’ve talked about some of the sort of AI infusion initiatives in past quarters. So I’m just wondering, number one, kind of catch us up in terms of what’s happening with the specific logos, and I think Accruent has been kind of an area of maybe lagging growth—maybe just bring us up to speed in terms of what’s happening there.

Olumide Soroye (President and CEO)

Yeah, thanks, Nigel. So the short answer is we’re very pleased with our software businesses across FAL and the healthcare software businesses in the quarter. I think from a FAL point of view, again, like I mentioned, the IOS segment performance—one of the beautiful things about it is it wasn’t just Fluke, but FAL and Gas Detection all contributed to that. So we talked about a 9.1% growth for IOS in the quarter. All three components were pretty close to that range.

Fluke was slightly ahead of the pack. So the fact that FAL could deliver at that level was a strong indication. The strong performance in FAL was led by ServiceChannel and Gordian. We continue to see really strong demand and adoption of the AI-enabled features that we’ve talked about the last couple of calls at ServiceChannel, and Gordian had another strong quarter led by procurement and planning solutions. Accruent continues on its journey of improvement, and we like the role it’s playing in the portfolio. And again, as a mix, the FAL group delivered very strongly.

On the healthcare side, the same thing. Our teams are doing a great job of deploying AI-enabled capabilities. We’ve talked about the AI-powered voice documentation at Provation. They’re doing a lot with leveraging the distinctive 30-year proprietary database that they have to generate new insights for customers that improve outcomes, and we’re seeing that continue to power success. So overall, like we said the last few calls, not all software businesses are the same.

The ones we have have some deeply embedded strengths that are multidimensional, and we’re seeing those play out really well in terms of enabling us to really turn AI into impact for customers, which is what they need.

Nigel Koh (Analyst at Wolfe Research)

That’s great. Thank you.

OPERATOR

Thank you. Our next questions come from the line of Scott Graham with Seaport Research Partners. Please proceed with your questions.

Scott Graham (Analyst at Seaport Research Partners)

Hey, good morning. I wanted to maybe drill down a little bit into the components issues that was asked previously. Are you buying mostly memory, or are you also buying a lot of logic?

Olumide Soroye (President and CEO)

Yeah, so I’ll take that. Thanks for the question. So, if you think about our bill of material across mainly our hardware businesses—so Fluke, ASP, the Fluke Health business, and Industrial Scientific—the bill of material has a little bit of logic in it; it has some memory in it. It’s not the high-band memory that competes with some of the intensely demanding use cases right now. So they’re really basic logic, some memory. What we’re finding—and again, we’ve been in this arena for a long time now—is that our teams are really good at making sure we have multiple sources of components, making sure that when there’s something that looks like it’s trending toward a choke point in terms of demand/supply that may not just, from an inflationary point of view, hike up the price, we build up inventory in advance in the right places and the right pockets. So we’re not in a place where this is a big topic for us, in part because the bill of material doesn’t have some of the more competitive components.

There are specific spots where we understand there could be exceptional inflation, and we manage that really well. So we feel good. Like Matt mentioned, price/cost was strongly positive in the quarter. Our teams do a really good job on components. Thank you for that. Just

Scott Graham (Analyst at Seaport Research Partners)

A follow-up would be, you mentioned the 100 basis point headwind in AHS. I was wondering if there was anything in IOS, and what both segments look like on a headwind basis for the fourth quarter.

Mark Okerstrom (Chief Financial Officer)

Yeah, happy to take that, Scott. I think you’re probably referring to the EBITDA margin headwind in AHS. It was predominantly in AHS. There was a little bit of a headwind in IOS as well. And as you recall in Q3 of last year, we talked about some of these discrete items which were largely related to incentive compensation and some capitalized software development items. But most of the impact was in AHS. I think as we look forward again, I would just call your attention to our prepared remarks. We do continue to expect to be able to deliver EBITDA margin expansion on a full-year basis in the 50 to 100 basis point zone, and we talked about being around the midpoint of that. So you can back into what that implies for Q4. But we like the momentum the business is carrying. I think as Olumide said, Fortive Accelerated is working, and over the medium term we expect that to drive a good formula of accelerating core growth and EBITDA margin expansion while we invest to drive more growth and also deliver to the bottom line.

Thank you both.

Scott Graham (Analyst at Seaport Research Partners)

Thank you.

OPERATOR

Thank you. Our next questions come from the line of Andy Klaplowitz with Citigroup. Please proceed with your questions.

Andy Klaplowitz (Analyst at Citigroup)

Hello everyone. I know you gave us an update — you’ve been talking about Fortive Accelerated today — but I think at your original investor day you talked about getting to a higher growth state from the program versus the 3% to 4% longer-term expected core growth by ’28. Is it reasonable to assume that you’re a bit ahead of plan on innovation and commercialization, or is it just more accelerated market growth that you’re seeing? I would assume it’s reasonable to say that you’ll have a higher contribution from innovation and commercialization in ’27.

Olumide Soroye (President and CEO)

Yeah, thanks for the question. I think if you go back to Mark’s comments in our prepared remarks that we’re now for the full year tracking just north of 5% core growth for the year, I think that’s a fair indication that we’re ahead of what we expected in terms of the 3% to 4% ’26–’27 kind of medium-term financial framework. And I think that is a combination of some of the markets we’re in having a really strong year and the impact of the innovation, commercial, recurring customer value actions that our teams are taking continue to ramp, and we’re still early in the ramp of those things.

So we really like the setup looking into ’27 and ’28. I think to your point we did have the plus-plus in ’28 and beyond on that financial framework across core growth, adjusted margins, and EPS growth, and everything we’re seeing is increasing our conviction that that plus-plus is certainly available to us and we’re going to do everything we can to get to it as quickly as we can. And our teams are excited and executing at a high level.

Andy Klaplowitz (Analyst at Citigroup)

That’s helpful. And then maybe just a little more color on regional demand that you’re seeing in IOS. I think you mentioned Americas had modest sequential growth, but Europe and the Middle East accelerated, which is interesting. So I was hoping you could comment a little more on that, and then what you’re seeing in China.

Olumide Soroye (President and CEO)

Yeah, thanks for that. So, I mean, all the regions did really well, and again it’s great when you have a session where you’re winning on multiple fronts. North America certainly continued to be the pacesetter and the fastest grower. In Europe, we saw the region with a little bit of softness in Q2. POS, like I mentioned on the last earnings call, actually remained strong in Q2, even though orders were a little bit slower. And then in Q3, we saw a bounce-back, so we saw growth return, POS remained constructive in the region.

I think the Middle East for us is, again, it’s 2% of our revenue, so it’s small, but it continued to actually show real strength, again in part because the things we do are essential and continue to be in demand, and our teams continue to do a really good job on making sure we can deliver. Thankfully, a lot of our business is oriented towards the Kingdom of Saudi Arabia, so we’re still able to do what we need to do. And APAC, again, really played a solid role for us.

China remains somewhat challenged and choppy, but the rest of APAC, especially India, for example, more than compensated for that. So across the regions, we like what we’re seeing and the momentum that our businesses are building from building more commercial capacity in some of these markets and tailoring innovation for some of these markets, specifically China. Our China strategy, for example, continues, and we’ll keep doing things like that to localize for the outside-of-the-US markets.

Andy Klaplowitz (Analyst at Citigroup)

Appreciate all the color.

OPERATOR

Thank you. Our next questions come from the line of Andrew Piscaglia with BNP Paribas. Please proceed with your questions.

Andrew Piscaglia (Analyst at BNP Paribas)

Hey, good afternoon, everyone.

Olumide Soroye (President and CEO)

Good afternoon.

Andrew Piscaglia (Analyst at BNP Paribas)

Wanted to dig into capital allocation a little bit. Since you spun off or separated from Ralliant, you repurchased about 13% of your shares, it seems like. So going forward, I know you do still talk about M&A as on the table, but at these levels, what return hurdles in your mind make an acquisition more attractive than just continuing to buy back stock the way you’ve been?

Mark Okerstrom (Chief Financial Officer)

Yeah, thanks. I’ll be happy to take that. As you call out, we have definitely had a bias over the course of the last five quarters to repurchasing our own shares. We do view M&A and share repurchase as interchangeable based upon relative returns. We have had a pretty attractive opportunity in our own stock, given the course and speed of the business, the free cash flow yield that we’ve seen compared to our after-tax cost of debt. Looking forward, we have revamped our M&A engine completely. We’ve augmented the team. We’ve changed our approach. We are building funnel. We’ve executed a few small bolt-ons. Obviously, we’re seeking to make sure that return on invested capital is ahead of our WACC in a reasonable period, but we’re also looking at free cash flow per share and EPS accretion/dilution on a comparative basis versus the two, taking into account the increased risk with M&A. Looking forward, our hope is that M&A could be a bigger piece of the equation and we like what we see from a funnel perspective. We will remain disciplined. We’ve got a couple of integrations under our belt that are performing really well, and we’ll continue to be dynamic based upon what we see.

Andrew Piscaglia (Analyst at BNP Paribas)

And maybe staying with the topic of M&A, I wonder, based on some of the comments you guys mentioned today on Advanced Healthcare, it’s a steady, albeit low-growth business and you have some margin opportunity there. But is M&A a tool you think you need to use to boost organic growth long term in that segment?

Olumide Soroye (President and CEO)

Yeah. Look, I think the primary thesis in our Fortive strategy is that we have the runway from a profitable organic growth acceleration point of view in both of these segments to create a lot of value for our shareholders. So our first order of business is the innovation, the commercial acceleration, and the recurring customer value work that our teams are doing. Bolt-on M&A is a sweetener, and we will do it in places where the financial and strategic criteria is compelling to max point versus share buybacks.

In our AHS segment we have a lot of runway from organic execution — trying to get stronger propositions for ambulatory surgical centers, trying to refresh innovation of our products, capture the impact of AI in our AHS software businesses — we have a lot to do. If we find things that are, no pun intended, surgically helpful to accelerate growth in the segment, we’ll do that. We talked about UV Smart on our last call. That was a great example of a very targeted bolt-on to ASP that brings in a new modality for disinfecting instruments of a very high value and highly important category to customers.

So we’ll do things like that. It will be very targeted and surgical. We don’t think we need to bank on that to do what we need to do in the segment, but we’ll be targeted with it.

Andrew Piscaglia (Analyst at BNP Paribas)

Got it. Thank you.

OPERATOR

Thank you. This does now conclude today’s question and answer session. I would now like to hand the call back over to management for any closing remarks.

Olumide Soroye (President and CEO)

Well, thank you, and thank you all for joining us today. We look forward to speaking with you next quarter. Have a great day.

OPERATOR

Thank you. This does now conclude today’s teleconference. We appreciate your participation. You may disconnect your lines at this time. Enjoy the rest of your day.

Disclaimer: This transcript is provided for informational purposes only. While we strive for accuracy, there may be errors or omissions in this automated transcription. For official company statements and financial information, please refer to the company’s SEC filings and official press releases. Corporate participants’ and analysts’ statements reflect their views as of the date of this call and are subject to change without notice.